Household Income Losses Associated With Ischaemic Heart Disease For US Employees

Authors: Herrin J.1; Cangialose C.B.2; Boccuzzi S.J.3; Weintraub W.S.4; Ballard D.J.5

Source: PharmacoEconomics, Volume 17, Number 3, 1 March 2000 , pp. 304-314(11)

Publisher: Adis International

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

Objective: To estimate the cost of lost work days due to ischaemic heart disease (IHD), and the cost of this reduced productivity using reduction in household income.

Design and setting: Using 2 years of nationally representative observational data, this study examined the effect on household income of IHD. This effect was estimated after accounting for unemployment, days lost to illness and other effects of illness on the income of workers aged 18 to 64 years.

Main outcome measures and results: Previous measures of indirect costs of disease have typically not included the loss in productivity due to suboptimal work performance. Among workers in this age group, IHD was associated with a reduction of $US3013 in annual household income; this reduction was independent of occupational class, age, size of household and educational level. Such a reduction may be because of reduced on-the-job performance, employer perception of this, or unrelated lifestyle choices. It represents an estimated $US6.05 billion annual loss in productivity in 1992 dollars (or $US6.45 billion in 1996 dollars).

Conclusions: Estimates of the indirect costs of chronic disease that do not account fully for the lost income of employees may significantly underestimate the benefits to employers and society of treatment and prevention.

Keywords: Cost of illness; Ischaemic heart disorders, treatment; Pharmacoeconomics

Document Type: Original article

Affiliations: 1: National Institute of Public Health, Oslo, Norway 2: Health Services Research Centre, Victoria University of Wellington and Wellington School of Medicine, Wellington, New Zealand 3: Merck & Co. Inc., West Point, Pennsylvania, USA 4: Division of Cardiology, Emory University, Atlanta, Georgia, USA 5: Baylor Health Care System, Dallas, Texas, USA

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$62.95 plus tax      Refund Policy

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A